Inovio wins prestigious Edward Jenner Poster Award for cervical cancer vaccine research
Written on Oct 5, 2011
Inovio Pharmaceuticals (AMEX:INO) announced Wednesday that it has won the Edward Jenner Poster Award First Prize for its research to develop a therapeutic, synthetic vaccine for cancer, at the recent fifth Vaccine and ISV Global Congress.
Inovio’s poster, entitled “Induction of HPV specific CTLs...
Advanced Cell receives green light from independent monitoring board to move forward with US trials
Written on Sep 29, 2011
Advanced Cell Technology (OTCBB:ACTC) said Wednesday that it has received approval from the independent Data and Safety Monitoring Board to move forward with enrolling and treating the next set of patients in each of its two US stem cell clinical trials.
In July, surgeons treated the first patients in the...
QLT receives two fast track designations for degenerative eye disease drug
Written on Sep 14, 2011
QLT (TSE:QLT) (NASDAQ:QLTI) announced Wednesday it received two fast track designations from the U.S. FDA for the speedy development of its QLT091001 drug, intended for the treatment of two degenerative eye diseases, Leber Congenital Amaurosis (LCA) and Retinitis Pigmentosa (RP).
Both LCA and RP are...
NanoViricides Reports Positive Anti-viral Effect of HIV Drug
Written on Aug 15, 2011
NanoViricides (OTCBB:NNVC) announced Monday that its anti-HIV drug candidate, HIVCide, achieved a positive, long-term effect with fewer and weaker doses than the traditional anti-retroviral combination therapy.
In a recent study with mice, the West Haven, Connecticut-based company found that the...
Bacterin Receives $15 Million Credit Facility
Written on Aug 5, 2011
Bacterin International Holdings (AMEX:BONE) announced Tuesday it secured a 42 month-long, $15 million credit facility with MidCap Financial LLC and Silicon Valley Bank.
The developer of bone graft materials and anti-infective coatings for medical applications received the first $7.0 million tranche to close...
IntelliCell BioSciences To Open Adipose Tissue Processing Center in Houston
Written on Aug 5, 2011
IntelliCell BioSciences, Inc. (OTCQB: SVFC), maker of stromal vascular fraction that contains adipose derived adult stem cells, said it has signed a deal to open an adipose stem cell processing center in Houston, Texas.
The plant, which the company plans to open in the next six weeks, would make adipose...



